SCICLONE PHARMACEUTICALS INC 4
4 · SCICLONE PHARMACEUTICALS INC · Filed Mar 17, 2017
Insider Transaction Report
Form 4
Low Raymond Anthony
VP, Finance & Controller
Transactions
- Exercise/Conversion
Common Stock
2017-03-15+1,250→ 13,513 total - Exercise/Conversion
Restricted Stock Unit
2017-03-15+1,250→ 22,500 totalExercise: $0.00Exp: 2026-03-15→ Common Stock (1,250 underlying)
Footnotes (4)
- [F1]Includes 613 shares and 742 shares purchased under the Issuer's Employee Stock Purchase Plan on August 31, 2016 and February 29, 2017, respectively.
- [F2]Granted under the Issuer's 2015 Equity Incentive Plan.
- [F3]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F4]Vesting for such RSUs will occur 25% on March 15, 2017, 25% on March 15, 2018, 25% on March 15, 2019, and 25% on March 15, 2020, contingent upon the executive's continued employment.